Quinoline Compounds Broad-Spectrum Antiviral Activity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antiviral treatments for viral infections, such as influenza and other viral diseases, lack effective compounds that can target and inhibit viral replication and infection efficiently, particularly for a wide range of viruses including influenza, Hepatitis C, and HIV.
Innovation Solution
Development of specific quinoline compounds with potent anti-viral activity, including 2-(5-methyl-1-phenyl-1H-pyrazol-4-yl)quinoline-4-carboxylic acid and its analogs, which can be administered to treat viral infections by inhibiting viral replication and cytopathic effects, and are effective against various viruses like influenza, Hepatitis C, and HIV.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional antiviral drugs are used to target viral hemagglutinin, neuraminidase, M2 ion channel, or 3P polymerase complex, then specific viral stages are inhibited, but the treatment is limited to specific virus types and mechanisms
Solution Approach 1:
The quinoline compound is designed to perform multiple antiviral functions through a single mechanism. It simultaneously exhibits activity against influenza virus, HIV, and Hepatitis C virus by interfering with viral replication processes, making it a universal antiviral agent that does not require separate drugs for different virus types
Solution Approach 2:
The invention changes the fundamental parameter of antiviral mechanism from targeting specific viral surface proteins or polymerases to interfering with viral RNA replication at an earlier stage. The quinoline compound's ability to inhibit viral replication through RNA interference represents a parameter change in the mode of action, enabling broad-spectrum activity across different virus families
2Reliability
If quinoline compounds are developed to inhibit viral replication, then broad anti-viral activity is achieved, but the molecular structure complexity increases
Solution Approach 1:
The quinoline compound acts as an intermediary molecule that mediates the inhibition of viral replication. Rather than directly targeting viral proteins, it interferes with the viral RNA replication process, serving as a chemical mediator between the host cell machinery and the viral replication cycle, thereby achieving reliable antiviral effects
Solution Approach 2:
The quinoline compound represents a composite molecular structure combining the quinoline core with various substituent groups (R1, R2, R3, X, Y). This composite molecular architecture allows optimization of both antiviral efficacy and pharmacological properties, achieving reliable anti-viral activity while maintaining manageable structural complexity through systematic molecular design
Data Source
AI summary
Quinoline compounds of formula (I):in which A, B, D, E, F, G, R1, R2, R3, X, Y, n, p, and q are defined herein. Also disclosed is a method for treating a viral infection with a compound of formula (I).